Law Firm · Petitioner PracticeVICP Petitioner PracticeLast verified
Cases filed
2
Comp rate
100%
Total awarded
$73K
Tenure
2018–2020
⚠Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the firm directly or with source court records before relying on them.
Robert Oushalem is a U.S. law firm whose name appears on 2 petitions in the National Vaccine Injury Compensation Program. The firm's filings on file span 2018-2020, with a compensation rate of 100%. Cases on file have produced $73K in total awards. The attorneys appearing on this firm's docket include Robert Oushalem.
AI-generated overview · may contain errors. Verify details with the firm directly before relying on them.
Answers built from this firm's public case docket.
How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. You can submit a free inquiry → to have your case forwarded to attorneys with VICP experience, or research Robert Oushalem's case history below.
How many VICP cases has Robert Oushalem filed?
Robert Oushalem has filed 2 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2018 and 2020.
What is Robert Oushalem's compensation rate?
Robert Oushalem's overall compensation rate across 2 VICP cases is 100% (2 compensated).
How much has Robert Oushalem won in VICP cases?
Cases filed by Robert Oushalem have resulted in $73K in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).
What kinds of vaccine injury cases does Robert Oushalem handle?
Based on the cases on file, Robert Oushalem's practice includes Encephalitis / encephalopathy, Guillain-Barré Syndrome (GBS), among other vaccine-related conditions.